Veeravich Jaruvongvanich1,2, Anawin Sanguankeo3,4, Sikarin Upala3,4. 1. Department of Internal Medicine, University of Hawaii, Honolulu, HI, USA. 2. Department of Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand. 3. Department of Internal Medicine, Bassett Medical Center and Columbia University College of Physicians and Surgeons, Cooperstown, NY, USA. 4. Department of Preventive and Social Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Abstract
BACKGROUND: Whether hypothyroidism is related to nonalcoholic fatty liver disease (NAFLD) is unclear. Thyroid dysfunction is closely related with components of metabolic syndrome. Given the hepatic manifestation of metabolic syndrome, several studies have investigated the association between NAFLD and thyroid dysfunction and have demonstrated inconsistent results. Thus, we conducted a systematic review and meta-analysis to better characterize the association between NAFLD and thyroid dysfunction. METHODS: MEDLINE and Embase were searched through July 2016. The primary outcome was the association between NAFLD and subclinical, overt, and overall hypothyroidism. The secondary outcome was the difference in thyroid hormone levels (free triiodothyronine [FT3], free thyroxine [FT4], or thyroid-stimulating hormone [TSH]) between NAFLD patients and non-NAFLD controls. Pooled odds ratios (OR) and 95% CI were calculated using a random-effects model. All continuous data are summarized as the mean difference along with 95% CI. RESULTS: Data were extracted from 14 studies involving 7,191 NAFLD patients and 30,003 controls. NAFLD was not associated with subclinical, overt, or overall hypothyroidism compared with non-NAFLD controls. Patients who had NAFLD did not show a significant difference in FT3, FT4, or TSH compared with non-NAFLD controls. CONCLUSIONS: Our meta-analysis demonstrates no significant association between NAFLD and subclinical, overt, or overall hypothyroidism, and we also found no significant difference in thyroid hormone levels between participants with and without NAFLD.
BACKGROUND: Whether hypothyroidism is related to nonalcoholic fatty liver disease (NAFLD) is unclear. Thyroid dysfunction is closely related with components of metabolic syndrome. Given the hepatic manifestation of metabolic syndrome, several studies have investigated the association between NAFLD and thyroid dysfunction and have demonstrated inconsistent results. Thus, we conducted a systematic review and meta-analysis to better characterize the association between NAFLD and thyroid dysfunction. METHODS: MEDLINE and Embase were searched through July 2016. The primary outcome was the association between NAFLD and subclinical, overt, and overall hypothyroidism. The secondary outcome was the difference in thyroid hormone levels (free triiodothyronine [FT3], free thyroxine [FT4], or thyroid-stimulating hormone [TSH]) between NAFLD patients and non-NAFLD controls. Pooled odds ratios (OR) and 95% CI were calculated using a random-effects model. All continuous data are summarized as the mean difference along with 95% CI. RESULTS: Data were extracted from 14 studies involving 7,191 NAFLD patients and 30,003 controls. NAFLD was not associated with subclinical, overt, or overall hypothyroidism compared with non-NAFLD controls. Patients who had NAFLD did not show a significant difference in FT3, FT4, or TSH compared with non-NAFLD controls. CONCLUSIONS: Our meta-analysis demonstrates no significant association between NAFLD and subclinical, overt, or overall hypothyroidism, and we also found no significant difference in thyroid hormone levels between participants with and without NAFLD.
Entities:
Keywords:
Hypothyroidism; Meta-analysis; Nonalcoholic fatty liver disease; Thyroid function
Authors: Stergios A Polyzos; Konstantinos N Aronis; Jannis Kountouras; Dimitrios D Raptis; Maria F Vasiloglou; Christos S Mantzoros Journal: Diabetologia Date: 2015-09-26 Impact factor: 10.122
Authors: Yenna Lee; Young Joo Park; Hwa Young Ahn; Jung Ah Lim; Kyoung Un Park; Sung Hee Choi; Do Joon Park; Byung-Chul Oh; Hak C Jang; Ka Hee Yi Journal: Endocr J Date: 2013-06-12 Impact factor: 2.349
Authors: Till Ittermann; Robin Haring; Henri Wallaschofski; Sebastian E Baumeister; Matthias Nauck; Marcus Dörr; Markus M Lerch; Markus Lerch; Henriette E Meyer zu Schwabedissen; Dieter Rosskopf; Henry Völzke Journal: Thyroid Date: 2012-05-10 Impact factor: 6.568
Authors: Paul Manka; Lars Bechmann; Jan Best; Svenja Sydor; Lee C Claridge; Jason D Coombes; Ali Canbay; Lars Moeller; Guido Gerken; Heiner Wedemeyer; Wing-Kin Syn Journal: Dig Dis Sci Date: 2019-06-03 Impact factor: 3.199
Authors: Maria de Fátima Haueisen Sander Diniz; Alline Maria Rezende Beleigoli; Isabela M Benseñor; Paulo A Lotufo; Alessandra C Goulart; Sandhi Maria Barreto Journal: PLoS One Date: 2020-02-07 Impact factor: 3.240
Authors: Marta Borges-Canha; João Sérgio Neves; Fernando Mendonça; Maria Manuel Silva; Cláudia Costa; Pedro M Cabral; Vanessa Guerreiro; Rita Lourenço; Patrícia Meira; Daniela Salazar; Maria João Ferreira; Jorge Pedro; Ana Leite; Madalena Von-Hafe; Catarina Vale; Sara Viana; Ana Sande; Sandra Belo; Eva Lau; Paula Freitas; Davide Carvalho Journal: Front Endocrinol (Lausanne) Date: 2020-10-28 Impact factor: 5.555